CLAIM #12132 · Bristol-Myers Squibb Company (BMY) · 2025Q1 earnings call · Apr 24, 2025 · due Dec 31, 2025
“There is, of course, ADAPT, which is very eagerly awaited... a small opportunity would be in myelofibrosis, that will read out later this year.”
Samit Hirawat · Chief Medical Officer
PENDING
graded after results covering Dec 31, 2025 are reported
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2025Q1 earnings call.